International multicenter examination of MOG antibody assays

International multicenter examination of MOG antibody assays

<p><strong>Objective</strong> To compare the reproducibility of 11 antibody assays for immunoglobulin (Ig) G and IgM myelin oligodendrocyte glycoprotein antibodies (MOG-IgG and MOG-IgM) from 5 international centers.</p> <p><strong>Methods</strong> The follo...

Full description

Bibliographic Details
Main Authors:	Reindl, M, Schanda, K, Woodhall, M, Ramberger, M, Leite, MI, Palace, J, Irani, SR, Waters, P
Format:	Journal article
Language:	English
Published:	Lippincott, Williams and Wilkins 2020

Similar Items

A multicenter comparison of MOG-IgG cell-based assays
by: Waters, P, et al.
Published: (2019)

An international multicentre validation experiment for MOG antibodies
by: Reindl, M, et al.
Published: (2018)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
by: Pace, S, et al.
Published: (2021)

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
by: Waters, P, et al.
Published: (2015)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
by: Waters, P, et al.
Published: (2015)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
by: Jurynczyk, M, et al.
Published: (2016)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
by: Elsone, L, et al.
Published: (2014)

Recurrent optic neuritis associated with MOG antibody seropositivity
by: Chang, T, et al.
Published: (2017)

MOG-IgA as a potential marker of germinal center activity
by: Handel, AE, et al.
Published: (2024)

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies.
by: Morris, K, et al.
Published: (2015)

Disease course and disability outcomes in MOG-antibody disease in the UK
by: Jurynczyk, M, et al.
Published: (2017)

No strong HLA association with MOG antibody disease in the UK population
by: Grant-Peters, M, et al.
Published: (2021)

Clinical presentation and prognosis in MOG-antibody disease: a UK study
by: Jurynczyk, M, et al.
Published: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
by: Jurynczyk, M, et al.
Published: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
by: Jurynczyk, M, et al.
Published: (2017)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
by: Waters, P, et al.
Published: (2016)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
by: Jarius, S, et al.
Published: (2018)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
by: Yeo, T, et al.
Published: (2020)

MOG-IgG1 antibodies in children
by: Waters, P, et al.
Published: (2018)

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
by: Whittam, DH, et al.
Published: (2020)

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
by: Juryńczyk, M, et al.
Published: (2016)

We need to talk about MOG
by: Waters, P, et al.
Published: (2020)

Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases
by: Kim, Y, et al.
Published: (2020)

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
by: Kaneko, K, et al.
Published: (2016)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
by: Sato, D, et al.
Published: (2014)

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
by: Waters, P, et al.
Published: (2012)

Prospective clinical and MRI characterization of children with serum anti-MOG antibodies meeting the multiple sclerosis diagnostic criteria
by: Fadda, G, et al.
Published: (2018)

Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders
by: Rinaldi, S, et al.
Published: (2020)

Peripheral nervous system involvement in MOG antibody-associated demyelination
by: Ramanathan, S, et al.
Published: (2019)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
by: Sato, D, et al.
Published: (2014)

Anti-MOG Antibody Seropositive Patient Successfully Treated with Intermittent Rituximab Infusion
by: Kim, W, et al.
Published: (2014)

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis
by: Hyun, J, et al.
Published: (2018)

Teratoma-derived glycine receptor antibodies in progressive encephalomyelitis with rigidity and myoclonus
by: Sun, B, et al.
Published: (2019)

Humoral signatures of MOG-antibody-associated disease track with age and disease activity
by: Spatola, Marianna, et al.
Published: (2023)

AQUAPORIN-4 M 23 ISOFORM PROVIDES A MORE SENSITIVE ASSAY FOR AQUAPORIN-4 ANTIBODIES
by: Waters, P, et al.
Published: (2010)

Utility of live cell-based assays for autoimmune neurology diagnostics
by: Woodhall, M, et al.
Published: (2022)

MOG-IGG IN NMO AND NMO-LIKE DISORDERS
by: Luppe, S, et al.
Published: (2014)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
by: Kitley, J, et al.
Published: (2013)

NMDA receptor antibody encephalitis presenting as Transient Epileptic Amnesia
by: Savage, SA, et al.
Published: (2019)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
by: Kezuka, T, et al.
Published: (2014)